Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tackling Three Key Issues In China’s Health Reform

This article was originally published in PharmAsia News

Executive Summary

Han Qi-de, vice chairman of the Standing Committee of the National People's Congress and President of Peking University Health Science Center, believes that three key problems exist in China's health care reform: health care availability, fairness and cost. Addressing the issues means establishing basic health care organizations, closing the gap between urban and rural areas, and offering medical care at affordable prices, respectively. There is a need to concurrently reform pharmaceutical production and distribution systems, as well as adopt practical measures to cut drug costs. Strict new drug approval processes, modern logistics in distribution, transparent medical income records in hospitals and a good legal system are some crucial factors toward achieving the objectives of the health reform. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068771

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel